Skip to main content

Table 2 Social and clinical characteristics of patients at the time of the interview 2 years after AMI

From: Long-term secondary prevention of acute myocardial infarction (SEPAT) – guidelines adherence and outcome

 

Groups

Variables

All

N = 200

Men

N = 158

Women

N = 42

Age, years, mean ± SD

65.5 ± 9.8

64.7 ± 9.5

68.2 ± 10.2

Social factors

 Born in Swedena n = 199 (%)

158 (79.3)

123 (77.8)

35 (83.3)

 Higher educationa n = 200 (%)

47 (23.5)

35 (22.2)

12 (28.6)

 Currently workinga n = 199 (%)

72 (34.4)

62 (39.2)

10 (23.8)

Smokinga n = 200

 Never (%)

62 (31.0)

45 (28.5)

17 (40.5)

 Regularly (%)

13 (6.5)

13 (8.2)

0 (0.0)

 Sometimes (%)

12 (6.0)

11 (7.0)

1 (2.4)

 Quit (%)

113 (56.5)

89 (56.3)

24 (57.1)

Exercisea n = 200

 Sedentary n (%)

28 (14)

18 (11.4)

10 (23.8)

 Moderate activity n (%)

81 (40.5)

63 (39.9)

18 (42.9)

 Regular activity n, (%)

50 (25.5)

41 (35.9)

9 (21.4)

 Vigorous activity n, (%)

41 (20.5)

36 (22.8)

5 (11.9)

Cardiovascular diseases

 Atrial fibrillationa n = 196 (%)

29 (14.8)

19 (12.3)

10 (24.4)

 Known heart failurea n = 193 (%)

16 (8.3)

10 (6.5)

6 (15.8)

 Hypertensiona n = 194 (%)

123 (63.4)

93 (61.2)

30 (71.4)

 Diabetesa n = 197 (%)

43 (21.8)

37 (23.6)

6 (15)

 Stroke/TIAa n = 198 (%)

14 (7.2)

12 (7.7)

2 (4.9)

 Hyperlipidemiaa n = 180 (%)

115 (63.9)

90 (63.4)

25 (65.8)

 Previous MI n = 200 (%)

26 (13.0)

19 (12.0)

8 (19.0)

 Previous PCI n = 200 (%)

23 (11.5)

18 (11.4)

5 (11.9)

Non-cardiovascular disease

 Cancera n = 200 (%)

31 (15.5)

22 (13.9)

9 (21.4)

 COPD n = 193 (%)

39 (20.2)

29 (19.1)

10 (24.4)

 OSA n = 162 (%)

48 (29.6)

37 (29.6)

11 (29.7)

 Renal failure GFR < 60 n = 200 (%)

55 (27.5)

33 (20.1)

18 (42.9)

 Renal failure GFR < 30 n = 200 (%)

4 (2)

4 (2.5)

0 (0.0)

 Depressed for at least 2 consecutive weeks in the past 12 monthsa n = 200 (%)

30 (15)

20 (12.7)

10 (23.8)

  1. Data were presented as n (%)
  2. TIA transient ischemic attack, MI myocardial infarction, PCI percutaneous coronary intervention, COPD chronic obstructive pulmonary disease, OSA obstructive sleep apnea
  3. aSelf-specified answers to questions in the SEPAT questionnaire